Lohman Technologies announced a deepened strategic partnership with Salvo Health, a leading virtual care platform for GI and metabolic conditions. The effort builds on the successful 2024 collaboration that integrated home monitoring into Salvo’s wraparound care model for IBS and IBD GI patients, leveraging heart rate variability (HRV) as an indicator of progress for Salvo’s brain-gut and behavioral health programs.

Board expansion accelerates commercialization pipeline of explainable AI and scalable RPM partnerships.

Healthcare providers can now keep a closer watch over patients at-risk for cardiac events and subsequent deterioration before (and after)...

Lohman Technologies announced today its strategic partnership with Salvo Health, uniting to bring innovative solutions to market.

The HomECG+ provides a low-cost alternative to remote cardiac monitoring for the millions of people at rish of AFib.

Cardiologists assume the responsibility for managing care of some of the most medically fragile patients.